Innogenetics NV is a Belgium based company that develops value-added diagnostics (especially theranostics) focusing on infectious disease, neurodegeneration and genetic predisposition testing. The principal products marketed are INNO-LIA™, INNO-LiPA and INNOTEST(TM). In 2001, the company had a turnover and R&D expenditure of €59.1 M and €23.8 M respectively. Innogenetics intends to expand its business alliances with selected multi-national pharmaceutical and diagnostic companies.